protein

Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein, CF

9178-PL-100

100 ug (also 1 mg)

443 USD

9178-PL-100

Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein, CF

100 ug (also 1 mg)

The Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein, CF from R&D Systems is derived from HEK293. The Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.

PD-L2/B7-DC

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose.

Unconjugated

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

Cynomolgus Monkey

62-77 kDa, reducing conditions

49 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Human PD-1 Fc Chimera (Catalog # 1086-PD ) is immobilized at 1 ╡g/mL, 100 ╡L/well, the concentration of Recombinant Cynomolgus Monkey PD-L2/B7-DC Fc Chimera that produces 50% of the optimal binding response is approximately 0.1-0.6 ╡g/mL.

<0.10 EU per 1 ╡g of the protein by the LAL method.

Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein Bioactivity

XP_005581839

Bioactivity

Human embryonic kidney cell, HEK293-derived cynomolgus monkey PD-L2/B7-DC protein Cynomolgus Monkey PD-L2/B7-DC (Leu20-Pro219) Accession # XP_005581839 IEGRMD Human IgG1 (Pro100-Lys330) N-terminus C-terminus

HEK293

443 USD

B7-DC, bA574F11.2, Btdc, Butyrophilin B7-DC, Butyrophilin-like Protein, CD273, CD273 antigen, CD273PD-1 ligand 2, MGC142240, PD-1-ligand 2, PDCD1L2MGC142238, PDCD1LG2, PDL2, PDL2B7DC, PD-L2PDCD1 ligand 2, programmed cell death 1 ligand 2, Programmed death ligand 2

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.